AI from Patient ECGs Can Detect Cardiovascular Disease Risks Sooner, Suggests Study
|
By HospiMedica International staff writers Posted on 26 Oct 2023 |

Atherosclerotic cardiovascular disease, characterized by arteries that are narrowed or clogged due to fatty deposits, is the number one cause of death worldwide. Often, the condition is driven by coronary artery disease, which many people may have without even knowing it. Tools available to clinicians like the pooled cohort equation are used to evaluate a patient's 10-year risk of heart attacks and strokes, although these methods are not without flaws. Electrocardiograms (ECGs), which record the electrical activity of the heart, are commonly used tests. Artificial intelligence (AI) has the ability to recognize and analyze hidden disease patterns in these electrical signals. Now, a new study suggests that AI applied to patient ECGs could offer a more efficient way to assess the risk of heart disease.
According to the research, AI algorithms trained on ECG data can detect potential risks much earlier than existing risk-calculation methods. They can identify symptoms of coronary artery disease like arterial calcification and obstructions, as well as signs of previous heart attacks. The ECG-based AI for evaluating coronary artery disease risk was jointly created by at Mayo Clinic (Rochester, MN, USA) and Anumana, Inc. (Cambridge, MA, USA) using a retrospective analysis of electronic medical records from over seven million U.S. patients to train three distinct AI models. These models were designed to spot coronary artery calcium, arterial blockages, and poor movement in segments of the heart's left ventricle, which is an indicator of a past heart attack.
"Used together, the three independent ECG-AI models predicted which patients had a high risk of hidden coronary artery disease, and therefore a high risk of having a heart attack. This is important information to guide our conversations with patients at the point of care, especially since the AI was useful in calculating these risks for as short as three years," said Francisco Lopez-Jimenez, M.D., a cardiologist at Mayo Clinic. "Used alone, the pooled cohort equation estimates the 10-year risk of developing cardiovascular disease. The addition of ECG-AI to see hidden risks sooner has the potential to save more lives. This model may also help identify people who do not know they have coronary disease who may benefit from lifesaving therapies."
Related Links:
Mayo Clinic
Anumana, Inc.
Latest Critical Care News
- Magnetically Guided Microrobots to Enable Targeted Drug Delivery

- Smart Nanomaterials Detect and Treat Traumatic Brain Injuries Simultaneously
- Earlier Blood Transfusion Could Reduce Heart Failure and Arrhythmia in Heart Disease Patients
- 'Smart' Shirt Detects Epileptic Seizures in Real Time
- Skin Patch Measures Effectiveness of Flu/COVID Vaccines in 10 Minutes
- Complete Revascularization Reduces Risk of Death from Cardiovascular Causes
- Tiny Fish-Inspired Robots Navigate Through Body to Deliver Targeted Drug Therapy
- Coronary Artery Stenosis Could Protect Patients from Pulmonary Embolism Effects
- Sweat-Powered Sticker Turns Drinking Cup into Health Sensor
- Skin-Mounted 3D Microfluidic Device Analyzes Sweat for Real-Time Health Assessment
- New Therapeutic Brain Implants to Eliminate Need for Surgery
- Stem Cell Patch Gently Heals Damaged Hearts Without Open-Heart Surgery
- Biomaterial Vaccines to Make Implanted Orthopedic Devices Safer
- Deep Learning Model Predicts Sepsis Patients Likely to Benefit from Steroid Treatment
- Programmable Drug-Delivery Patch Promotes Healing and Regrowth After Heart Attack
- Breakthrough Ultrasound Technology Measures Blood Viscosity in Real Time
Channels
Surgical Techniques
view channel
New Study Findings Could Halve Number of Stent Procedures
When a coronary artery becomes acutely blocked during a heart attack, opening it immediately is essential to prevent irreversible damage. However, many patients also have other narrowed vessels that appear... Read more
Breakthrough Surgical Device Redefines Hip Arthroscopy
Hip arthroscopy has surged in popularity, yet surgeons still face major mechanical constraints when navigating deep joint spaces through traditional cannulas. Limited tool mobility and the need for an... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







